Altre lingue Zelira Therapeutics Limited

Azioni

ZLD

AU000000ZLD1

Mercato chiuso - Australian S.E. Altri mercati azionari 07:44:48 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,705 ^AUD	-0,70%		-0,70%	-21,67%

22/02	Zelira Therapeutics Limited riporta i risultati degli utili per il semestre conclusosi il 31 dicembre 2023	CI
08/01	Zelira Therapeutics ottiene una sovvenzione per il suo prodotto cannabinoide	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Zelira Therapeutics Receives AU$919,000 Funding Under Australian Government’s R&D Tax Incentive Scheme	15/04
Zelira Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	22/02
Zelira Therapeutics Secures Grant Funding for Cannabinoid Product	08/01
Zelira Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Zelira Therapeutics Limited Announces Board Changes	31/05/23
Zelira Therapeutics Bags Nearly AU$5 Million More Investment for HOPE SPV; Shares Rise 4%	22/05/23
Zelira Therapeutics Limited announced that it expects to receive $22 million in funding	22/05/23
Zelira Therapeutics Raises AU$1.8 Million Via Placement	15/03/23
Zelira Therapeutics Halts Securities Trading Pending Capital Raising Announcement	13/03/23
Zelira Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/02/23
Zelira Therapeutics Limited Promotes Greg Blake from VP - Global Head of Commercial and Partnering to Executive Director	20/02/23
Zelira Therapeutics Secures Nearly $9 Million Funding for US Clinical Trials of HOPE	15/02/23
Zelira Therapeutics Secures R&D Tax Rebate	30/01/23
Zelira Therapeutics Completes Drug Trial Patient Enrolment	21/11/22
Zelira Therapeutics Launches ZYRAYDI™ B2b Technology to Create Pharma-Grade Cannabis Capsules & Tablets for Global Markets	20/09/22
Zelira Therapeutics Enrolls Two-Thirds of Patients for Diabetic Nerve Pain Medication	15/09/22
Zelira Therapeutics Limited Completes Two-Thirds of Enrolment for Diabetic Nerve Pain Drug Trial	15/09/22
Zelira Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/08/22
Zelira Therapeutics Limited Auditor Raises 'Going Concern' Doubt	31/08/22
Zelira Therapeutics : June 2022 Quarterly Activities Report	29/07/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Zelira Therapeutics Limited

Azioni

ZLD

AU000000ZLD1

Altre lingue

Filtri